DJIA 18,070.40 46.34 0.26%
NASDAQ 5,016.93 11.54 0.23%
S&P 500 2,114.49 6.20 0.29%
market minute promo

RECEPTOS INC (NASDAQ: RCPT)

153.45 -2.95 (-1.89%)

Quote as of


company name or ticker

Recent Quotes

RCPT $153.45 -1.89%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $156.08
Previous Close $156.40
Daily Range $153.07 - $159.95
52-Week Range $24.53 - $203.25
Market Cap $4.8B
P/E Ratio -33.78
Dividend (Yield) $0.00 (0.0%)
Volume 762,800
Average Daily Volume 1,030,473
Current FY EPS -$5.43

Sector

Industry

RECEPTOS INC (RCPT) Description

RECEPTOS INC Website: http://www.receptos.com/

News & Commentary

3 Biotech Stocks That Could Be Developing Billion Dollar Drugs

These three clinical stage biotech companies are working on therapies addressing billion dollar indications.

Jim Cramer -- BioMarin, Receptos Will Re-Test Highs, Biotech Will Recover

Jim Cramer's Top Takeaways: Spirit Airlines and Receptos

Receptos Gains on Positive Phase II Data on Ozanimod - Analyst Blog

Receptos Extends Gains On Safety Study, Analyst's Launch

3 Drugs Stocks Pushing Industry Growth

Receptos (RCPT) Leading In Pre-Market Activity

Health Care Sector Update for 04/16/2015: ACAD, RCPT, HZNP

Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozan

Receptos Reports Positive Results for the Maintenance Period of the Phase 2 TOUCHSTONE Trial of Ozanimod in Ulcerative Colitis

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind

See More RCPT News...